HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased mRNA expression of the receptor-like protein tyrosine phosphatase alpha in late stage colon carcinomas.

Abstract
The protein tyrosine phosphatase alpha (PTP alpha) mRNA level in paired samples of late stage (Dukes' D) colorectal tumors and adjacent normal colon mucosa was quantified by RNase protection assays. After normalization against 18S RNA or beta-actin mRNA level, a 2-10-fold increase in PTP alpha mRNA was detected in 10 of 14 tumors (approximately 70%) compared to mucosa. In situ hybridization of digoxigenin-labelled antisense PTP alpha RNA to tumor and mucosa sections produced a signal only in neoplastic cells of the tumor sample, consistent with the high increase in PTP alpha mRNA detected by RNase protection assays of some of the tumors. This is the first report suggesting an association of a protein tyrosine phosphatase with colorectal carcinoma. PTP alpha is a receptor-like PTP thought to be involved in regulating cell proliferation. Its oncogenic properties when overexpressed in cultured fibroblasts suggest that PTP alpha overexpression could contribute to the tumorigenic process in colon carcinoma.
AuthorsK Tabiti, D R Smith, H S Goh, C J Pallen
JournalCancer letters (Cancer Lett) Vol. 93 Issue 2 Pg. 239-48 (Jul 13 1995) ISSN: 0304-3835 [Print] Ireland
PMID7621435 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Isoenzymes
  • RNA, Messenger
  • RNA, Neoplasm
  • Protein Tyrosine Phosphatases
Topics
  • Adenocarcinoma (enzymology, pathology)
  • Colonic Neoplasms (enzymology, pathology)
  • Humans
  • In Situ Hybridization
  • Intestinal Mucosa (enzymology)
  • Isoenzymes (metabolism)
  • Protein Tyrosine Phosphatases (metabolism)
  • RNA, Messenger (metabolism)
  • RNA, Neoplasm (metabolism)
  • Rectal Neoplasms (enzymology, pathology)
  • Sigmoid Neoplasms (enzymology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: